Insulin detemir
- Generic Name
- Insulin detemir
- Brand Names
- Levemir
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 169148-63-4
- Unique Ingredient Identifier
- 4FT78T86XV
- Background
Insulin detemir is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the pancreas that promotes glucose metabolism. Insulin ...
- Indication
Insulin detemir is indicated to improve glycemic control in adults and children with diabetes mellitus.
- Associated Conditions
- Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
- Associated Therapies
- -
Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
- Conditions
- Interventions
- First Posted Date
- 2007-11-27
- Last Posted Date
- 2019-10-11
- Lead Sponsor
- University of Texas Southwestern Medical Center
- Target Recruit Count
- 33
- Registration Number
- NCT00564018
- Locations
- 🇺🇸
Children's Medical Center, Dallas, Texas, United States
Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial
- Conditions
- Interventions
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2014-11-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 25
- Registration Number
- NCT00542620
Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 296
- Registration Number
- NCT00537303
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Rugby, United Kingdom
Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2007-08-29
- Last Posted Date
- 2014-09-03
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 18
- Registration Number
- NCT00522210
- Locations
- 🇨🇦
Alberta Children's Hospital, Calgary, Alberta, Canada
The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD
- Conditions
- First Posted Date
- 2007-08-28
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 25
- Registration Number
- NCT00521690
Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2007-08-01
- Last Posted Date
- 2017-03-10
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 23
- Registration Number
- NCT00509925
- Locations
- 🇬🇧
Novo Nordisk Investigational Site, Guildford, United Kingdom
Comparison of Insulin Detemir and NPH Insulin Given Once Daily in Ageing Subjects With Type 2 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 86
- Registration Number
- NCT00506662
Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes
- Conditions
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 277
- Registration Number
- NCT00504673
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)
- Conditions
- Interventions
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2009-11-11
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 442
- Registration Number
- NCT00494013
- Locations
- 🇨🇳
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Yung-Kang, Tainan, Taiwan
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
- Conditions
- First Posted Date
- 2007-06-25
- Last Posted Date
- 2007-06-25
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 12
- Registration Number
- NCT00490893
- Locations
- 🇩🇪
University of Tübingen, Medical Department, Tübingen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.